Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Narendranath Epperla, MD, MS
Huntsman Cancer Institute/ University of Utah
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sidney Kimmel Comprehensive Cancer Center at Jefferson
Philadelphia, Pennsylvania, United States
Iyad Alnahhas, MDRecruiting - Brown University Health Rhode Island Hospital
Providence, Rhode Island, United States
Not, yet, recruiting - Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Mar 2025
- Primary completion
- 30 Nov 2029
- Completion
- 30 Nov 2030
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 12
- Registry id
- NCT06607549
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.